NEW YORK (GenomeWeb News) — French company Laboratoires Fournier will license BioBase’s TRANSFAC eukaryotic gene-regulation database, BioBase said today.
BioBase said the Dijon-based company will use the database to develop therapeutics for metabolic and cardiovascular diseases.
BioBase, headquartered in Wolfenbuttell, Germany, said the TRANSFAC database holds information on 8,700 transcription factors and is used to identify and analyze binding sites.
The company said the database, which it updates every three months, also visualizes, interprets, and predicts gene-regulatory networks.
Financial terms of the agreement were not released.